CD28 and acute myeloid leukemia: In preclinical Molm-13 and THP-1 AML xenograft mouse models, CD70-inserted CAR-T cells were significantly more effective than CD70scFv G2 CAR constructs (either with CD28, 4-1BB, or CD27 domains) [88].